$INSM news
The latest INSM stock news: headlines, filings, AI summaries and sentiment for $INSM, updated around the clock.
- Nanoscope Therapeutics Appoints Damon Daulerio as Executive Director of Regulatory Affairs
- Insmed Reports Q3 2026 Revenue Growth of 268% Driven by BRINSUPRI Launch
- Insmed Shares Rise 13% Following Q3 Revenue Beat and Increased Full-Year Guidance
- Insmed Reports Q3 Revenue Beat Driven by Brensocatib Sales Despite GAAP EPS Miss
- INSMED Inc - 8-K Filing
- INSMED Inc - 10-Q Filing
- Insmed (INSM) Scheduled to Report Q3 2026 Earnings on October 28
- INSMED Inc - 8-K Filing
- Insmed's CFO Sara Bonstein to Step Down
- INSMED Inc - 8-K Filing
- Parnassus Growth Equity Fund Exits Position in Insmed (INSM) After Investment Thesis Realized
- American Century Investments Exits Position in Insmed Due to Disappointing Drug Uptake
- Insmed's New Drug Launch Transforms Financial Performance
- Stanley Druckenmiller's Duquesne Family Office Increases Healthcare Stock Holdings
- Concerns Over the Pace of Brinsupri's Launch Impact Insmed (INSM)
- INSMED Inc - 8-K Filing
- Mizuho Maintains Outperform Rating on Insmed (INSM) Despite Lowered Price Target
- Nasdaq-100 Index Adds Five New Members Focused on Tech Innovation
- CoreWeave (CRWV) Set to Join Nasdaq-100, Surges Over 9%
- Truist Lowers Price Target for Insmed Amid Competitive Pressures
- Insmed Reports Strong Q1 2026 Earnings and BRINSUPRI Performance
- Raymond James Initiates Coverage on Insmed with Outperform Rating